Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.5 -0.3 (-0.77%) Market Cap: 5.62 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.97 GF Score: 70/100

Ionis Pharmaceuticals Inc Technology Webcast Transcript

Dec 13, 2019 / 04:00PM GMT
Release Date Price: $63.05 (+1.33%)
Operator

Good morning, and welcome to the Ionis Technology Webcast. As a reminder, this webcast is being recorded.

At this time, I would like to turn the call over to Wade Walke, Vice President, Investor Relations. Wade, please begin.

D. Wade Walke
Ionis Pharmaceuticals, Inc. - VP of IR

Thank you, Sean. Before we begin, I encourage everyone who has not yet launched the webcast to proceed to the Investors section of the Ionis' website to find the link to this webcast and the related slides.

We'd like to draw your attention to Slide 2, which contains our forward-looking language statement. We will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.

With me on today's webcast are Dr. Stanley Crooke, Founder, Chairman and Chief Executive Officer. Under his leadership, Ionis pioneered development of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot